IP Group

IP Group, established in 2001 and based in London, focuses on creating value through the commercialization of intellectual property from research-intensive institutions. The firm excels in identifying suitable intellectual property for commercialization and is adept at developing businesses or forming strategic partnerships to maximize value. With a strong foundation of industry and financial expertise, IP Group has built a solid reputation for delivering consistent results for its companies, partners, and shareholders. By leveraging its extensive knowledge of the commercialization process, IP Group effectively bridges the gap between innovative research and market application, fostering growth and sustainability in its business endeavors.

Liz Vaughan Adams

Director of Communications

Alan Aubrey

Chief Executive Officer

Gregory Simon Smith

CFO and Executive Director

Greg Smith

Chief Financial Officer

Alastair Stewart

Partner, IP Capital

Stuart Thompson

Talent Partner & Head of IP Exec

Mike Townend

Chief Investment Officer

Liz Vaughan-Adams

Director of Communications & IR

496 past transactions

Zeetta Networks Limited designs, develops, and markets open networking solution based on software defined networking (SDN) and network virtualization technologies. It offers NetOS, a network operating system for heterogeneous networks, which provides a USB-like plug-n-play management of various connected network devices; and enables the construction of virtual network slices for the deployment of B2B or B2C services, such as ultra-HD video distribution, city-wide Wi-Fi, Internet of Things, M2M deployments, etc. The company also provides NetOS Enablers for vendor-specific programmable OpenFlow agents and SDN network applications; and acts as core network operating system incorporating the SDN controller and plug-in software extensions to NetOS and SDN controller. In addition, it offers integration, support, and training services; and network operator, enterprise, OEM vendor, and data center solutions. The company was incorporated in 2015 and is based in Bristol, United Kingdom.

CareAlign

Pre Seed Round in 2019
TrekIT provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care. Easily assign, date and time tasks, categorize them for when they are due, view cleared tasks and more.
CARDIAnove, Inc. designs and develops medical devices for the heart. It offers miniature implantable pumps, which are used as left ventricular support devices for treating congestive heart failure. The company was founded in 1997 and is based in Montreal, Canada.
Atlas Cloud are a leading provider of cloud IT services based in Newcastle upon Tyne with offices in Leeds, Sheffield & London. The Atlas Cloud team were early adopters of cloud technologies and with the expertise gained working with global, multi-national companies such as Acxiom, American Express, BT, Barclays, Cap Gemini, Siemens and Brewin Dolphin, are transforming the way that IT is provided to SMEs.

Epsilon-3 Bio Ltd.

Epsilon-3 Bio Ltd. develops therapeutic agents for removal of cellular debris in chronic inflammatory and autoimmune disorders. The company was founded in 2010 and is based in Cambridge, United Kingdom.
Ionix Advanced Technologies Ltd. develops and supplies piezoelectric devices and materials for high temperature applications. It offers a range of sensors, actuators, and transducer devices based on its high-temperature piezoelectric materials; and anisotropic piezoelectric ceramics for reducing ultrasonic array crosstalk and improve acoustic transmission. The company serves industrial plant process, aerospace, oil and gas, nuclear power, automotive, and ultrasound and NDT markets. Ionix Advanced Technologies Ltd. was founded in 2011 and is based in Leeds, United Kingdom.

C-Capture

Venture Round in 2019
C-Capture Ltd utilise their extensive knowledge of CO2 (carbon dioxide) based chemistry and engineering, to develop a bottom-up approach to designing solvent systems for the removal of CO2 from gas streams. CO2 is considered to be a ‘greenhouse gas’ and its release into the atmosphere is one of the leading contributors to global warming.
Human experience has economic impact. Actual Experience Analytics are used by businesses to quantify and improve the actual experience of key applications for their customers and users
Tissue Regenix was founded in May 2006, to commercialise innovative technologies in regenerative medicine. The underpinning science was developed over the last decade in the world-leading Institute for Medical and Biological Engineering at the University of Leeds by Professors John Fisher and Eileen Ingham. The research has received in excess of £4 million grant funding to date from UK research councils (EPSRC, BBSRC) and the Children's Heart Surgery Fund.
Inductosense is developing wireless, battery-free, sensors that can be permanently fixed to a product or structure for fast, repeatable inspections of cracks, defects or corrosion. The sensors can operate underneath coatings, insulation or repairs and can also be embedded into a material. They are entirely passive and the power and signal are provided remotely by non-contact inductive coupling from a handheld measurement probe . The technology is referred to as the Wireless And Non Destructive (WAND) system.
Econic Technologies Ltd., a chemical technology company, develops crystals and processes polymers and polyurethanes from carbon dioxide and epoxides in the United Kingdom. Its products include polycarbonates and polycarbonate polyols, which are used in mattresses and seats, home insulation, shoes, and packaging materials; glues and coatings for wires and piping; and building and construction, and other surfaces. Econic Technologies Ltd. was incorporated in 2011 and is based in Macclesfield, United Kingdom.

Oxular

Venture Round in 2021
Precision Ocular Metrology is a medical device startup dedicated to revolutionizing the way we measure ocular surface topography. Standard Placido disk slope measurements are great for optical power measurements on the central regions of the cornea but provide poor elevation topography, making them poor choices for specialty lens fitting. Our sMap3D topographer addresses this problem by providing direct anterior surface elevation measurements, letting you map the complete three-dimensional eye surface with an unprecedented 10 um precision.
Diurnal is an innovative pharmaceutical company that creates high-value therapeutics using advanced proprietary formulations and novel physiological treatment regimes of approved drugs for use in the endocrine (hormone) area.

Artios Pharma

Private Placement in 2018
Artios Pharma Limited, a biotechnology company, focuses on developing cancer treatments that target DNA damage response (DDR) pathways to selectively kill cancer cells. Its product pipeline includes DNA polymerase theta (Polθ), which is involved in multiple processes associated with DNA repair; an in-licensed program that targets a protein that has been identified as a novel DNA damage response target; and a novel cancer treatment targeting DNA nucleases involved in the DDR. The company was incorporated in 2015 and is headquartered in Cambridge, United Kingdom.
Relitect Limited engages in developing a technology for the detection of binding events, which can be used for the analysis of proteins, small molecules, and nucleic acids for clinical diagnostics and life sciences industries. The company was incorporated in 2014 and is based in Motherwell, United Kingdom.

Mobilion Systems

Series C in 2021
MOBILion Systems, Inc. develops structures for lossless ion manipulation (SLIM) for conducting ion mobility separations with lossless ion transfer and manipulation. It offers SLIM to separate and detect clinically relevant molecules that are indistinguishable by current instruments. The company’s SLIM enables researchers to detect and analyze molecules indicative of diseases, such as minute traces of disease specific biomolecules. The company was incorporated in 2015 and is based in Chadds Ford, Pennsylvania.
InhibOx Ltd. develops and delivers technologies and services in cloud-enabled and computer-aided drug discovery (CADD). It offers Scopius databases, which include Scopius-CSpace, a database of commercially available compounds; Scopius-FSpace, a fragment database of validated substructures derived from Scopius-CSpace by a qualified set of fragmentation rules; and Scopius-VSpace, a filtered database of readily synthesized molecules, derived from chemistries in combination with the drug-like molecules in Scopius-CSpace. The company also provides ligand-based virtual screening solutions, including ElectroShape, a method for ligand searching based on combinations of shape, charge, and various phyico-chemical properties; Fox, a method for shape-based screening of a library against a query molecule; MOx, a method for identifying structural similarity based on recognition of structural features; and Cover, a super-positional search method, as well as used to assess the steric overlap between molecules. In addition, it offers ligand-protein docking solutions, such as AutoDock, a ligand-protein docking program in the literature; DOx, a ligand docking and scoring software; The DOx Scoring Module that is used to evaluate the favorability of a generated molecular configuration; and CCDCGOLD, a docking system. Further, the company provides fragment-based design solutions, including LOx, which constructs chemically diverse ligands by making use of fragments in Scopius-FSpace. It provides lead identification and optimization solutions for contract research services; compound database and virtual library creation services, which include 3D searchable databases from compound collection, virtual libraries from in-house chemistries, and fragment databases to guide design projects; software and database licenses and Software as a Service solutions; and DrugFinder to support academic institutions. InhibOx Ltd. was founded in 2001 and is based in Oxford, United Kingdom.

IP2IPO Services Limited

IP2IPO Services Limited was incorporated in 2005 and is based in London, United Kingdom.
Oxford Biotrans Ltd is committed to commercialising new enzymatic routes to high value speciality chemicals based on its patented cytochrome P450 enzyme technology. The company is supported by over 15 years of research by Dr Luet Lok Wong from the Department of Chemistry at the University of Oxford. The first products to market will be flavours and fragrances. The technology also has applications in the production of pheromones, pharmaceuticals and other speciality chemicals.
MOBILion Systems, Inc. develops structures for lossless ion manipulation (SLIM) for conducting ion mobility separations with lossless ion transfer and manipulation. It offers SLIM to separate and detect clinically relevant molecules that are indistinguishable by current instruments. The company’s SLIM enables researchers to detect and analyze molecules indicative of diseases, such as minute traces of disease specific biomolecules. The company was incorporated in 2015 and is based in Chadds Ford, Pennsylvania.

Karus Therapeutics

Series B in 2012
Karus Therapeutics Limited is a biopharmaceutical company that develops medicines for cancer. Its portfolio includes orally-active small molecule drugs, including KA2237, a dual-selective inhibitor of PI3K isoforms, such as p110ß and p110d for treating hematological and solid tumors; and KA2507 (HDAC6) for PD-L1 expressing tumors. The company was incorporated in 2005 and is based in Oxfordshire, United Kingdom.
Marblar Ltd. provides an online networking site allowing inventors to post their discoveries and where researchers are encouraged to pitch their ideas on how the inventions could be used commercially. Marblar Ltd. is based in the United Kingdom.
Aptatek Biosciences Inc manufactures portable disease management devices for people suffering with Phenylketonuria (PKU). The products can be used to monitor phenylalanine levels. The product provides real time analyses and reports of blood using sensor technology. Aptatek Biosciences Inc is based in Princeton, New Jersey.

MoA Technology

Series B in 2022
MoA Technology Limited is a plant genetics company spun out from the University of Oxford. Professor Liam Dolan, FRS, has developed an innovative approach for the discovery of agricultural technologies that will enable farmers to produce healthy food from sustainable crop systems.

Oxehealth

Venture Round in 2014
Oxehealth Ltd. develops a non-contact vital signs technology to support medical and non-medical applications. The company offers Oxecam software, a medical technology to measure the patient’s heart rate, respiratory rate, and blood oxygenation by using a video camera. It serves the health care sector; gym and medical equipment providers; and automotive, security, and retail industries. The company was founded in 2012 and is based in the Oxford, United Kingdom.
A company at the top of its game in harnessing intelligent systems and emerging technologies. Working methodically but unobtrusively they set the gold standard in workplace automation. You can trust our proprietary and proven methodology to encapsulate your human know-how and the complex processes that characterise human decision-making.
Modern Biosciences plc is a virtual drug development company. The company engages in the in-licensing, project development, and commercialization of its products. It in-licenses late-stage discovery projects from academia and spin out companies. The company is based in London, the United Kingdom.
Yoyo Wallet is a U.K.-based mobile wallet startup that enables its users to pay for their goods with their smartphones. The company currently processes over 150,000 monthly in-store transactions by combining payment and loyalty via an easy scan. It also provides a marketing platform for retailers that enables digital customer engagement in-store. The multi-retailer mobile wallet offers loyalty programs and rewards offerings it can automatically deliver to customers based on buying patterns. Launched in 2013, Yoyo Wallet receives funding from Taavet Hinrikus and TransferWise.
Progenteq Ltd. develops cartilage repair therapy to regenerate damaged cartilage. It offers Allocart, an allogeneic cartilage repair therapy for the treatment of acute cartilage injuries. The company serves patients, surgeons, healthcare providers, and payors. Progenteq Ltd. was founded in 2009 and is based in Cardiff, United Kingdom.

First Light Fusion

Venture Round in 2011
First Light Fusion Limited discovers advanced implosion processes for electricity generation. First Light Fusion Limited was formerly known as Oxyntix Ltd. and changed its name to First Light Fusion Limited in June 2014. The company was founded in 2011 and is based in Begbroke, United Kingdom.
Crysalin Limited engages in the research and development of crysalin lattice technology for determining protein structures. Its portfolio includes crysalins, a protein-based nanotechnology for application in protein structure determination, as well as biosensor development and optoelectronics. The company was founded in 2007 and is based in London, United Kingdom.

Ankere Therapeutics

Seed Round in 2022
Ankere is striving to develop transformative therapies based on excellent science that will enable people to live long and healthy lives.

Applied Graphene Materials UK Limited

Applied Graphene Materials UK Limited researches and develops the synthesis of grapheme. The company offers graphene dispersions in the form of polymer matrices, adhesives, elastomers, and aqueous and non-aqueous solvents; and graphene powders. Its graphene products are used in capacitors and batteries, advanced composites, paints and coatings, oils and functional fluids, thermal management solutions, display materials, and inks and 3D-printers’ materials. Applied Graphene Materials UK Limited was formerly known as Durham Graphene Science Limited and changed its name to Applied Graphene Materials UK Limited in October 2013. The company was incorporated in 2010 and is based in Durham, United Kingdom. Applied Graphene Materials UK Limited operates as a subsidiary of Applied Graphene Materials plc.
Clyde Biosciences Ltd. offers developmental drug testing solutions that provide clients with insights into the working mechanisms and actions of drugs in research and development, as well as enable them to evaluate the drug toxicity. It develops cellOPTIQ, an optical action potential assay providing clients with an understanding of the effects of drug compounds on human cells to address unmet needs in testing cardiotoxicity risk in new and existing drugs. The company also develops XTENDSR, a solution that provides clients with direct measurements of drug induced changes on cardiac sarcoplasmic reticulum function. It serves pharmaceutical and biotechnology companies in the United Kingdom and internationally. Clyde Biosciences Ltd. was founded in 2012 and is based in Glasgow, United Kingdom.
Cynash delivers nature-inspired cybersecurity technologies to protect critical energy, transportation, wastewater and industrial control infrastructure. Their patented cybersecurity technologies build uFpon decades of applied research in machine learning, data analytics, high-performance computing and scalable infrastructure protection. They currently offer four interrelated cybersecurity technologies:

Oxford Advanced Surfaces Limited

Oxford Advanced Surfaces Limited develops and provides Onto surface treatments technology. The company was incorporated in 2006 and is based in Begbroke, United Kingdom. Oxford Advanced Surfaces Limited operates as a subsidiary of Oxford Advanced Surfaces Group plc.

Dynamic Vision Systems (DVS) Ltd

Dynamic Vision Systems (DVS) Ltd develops contact lens for the correction of presbyopia. It offers a wearer-operated, electrically switchable contact lens. The company was incorporated in 2014 and is based in Leeds, United Kingdom.
Karus Therapeutics Limited is a biopharmaceutical company that develops medicines for cancer. Its portfolio includes orally-active small molecule drugs, including KA2237, a dual-selective inhibitor of PI3K isoforms, such as p110ß and p110d for treating hematological and solid tumors; and KA2507 (HDAC6) for PD-L1 expressing tumors. The company was incorporated in 2005 and is based in Oxfordshire, United Kingdom.

Avacta Group

Post in 2015
Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. It is engaged in the research, development, production and delivery of instrumentation and services for the biopharmaceutical drug development and clinical diagnostics markets using biophysical technology. The Company has two segments: Analytical and Animal Health. The Analytical segment provides tools and contract services for early stage protein characterisation and analysis for biopharmaceutical drug developers. The Animal Health provides tools and contract services to assist diagnosis of conditions in animals to enable faster treatment for veterinarians. The Company’s subsidiaries include Avacta Limited, Avacta Analytical Limited, Oriental Fine Foods Limited, Avacta Health Limited, TheraGenetics Limited and TheraGenetics Inc. ###Readybuy Plc acquires Avacta Ltd in a reverse merger and changed name to Avacta Group Plc in 2004. Readybuy was founded in 2003.###

Reframed.tv

Seed Round in 2014
Reframed.tv is changing the way the world consumes, interacts with and shares video for the better. The company’s mission is to make video truly social. Users can create contextual conversations with time-specific comments in video, share them with deep links, follow users and favourite comments. It’s about building a community, moment by moment. Comments are synced to a video with a time-stamp so anyone can join the conversation with one tap, whether it’s an hour, a week, a year after the initial video release. It’s been referred to as “second-chance twitter.” Founded on 6th August 2013 by Jo York and Kev Price, who are based in Newcastle Upon Tyne, the idea was taken from concept to market trial in three months as part of the tech accelerator programme Ignite100. Reframed allows people to comment on, share and discuss moments in video. Our mission is to improve the experience and depth in which audiences connect with video content, generating engaging relationships between people who are moved by or resonate with the messages at specific moments. The Reframed interface timestamps comments at the exact moment the user starts typing. This information is used to display the comment at the relevant time in the video, giving them context. The comment activity is displayed visually in graph form over the timeline so users can instantly see the points in the video that are gaining interest and jump straight into those moments. Users often discuss this activity away from the video on social media sites, which are displayed in the order of the time and date they were made, not at the point in the video to which they refer. So, joining in the conversation becomes more difficult. Reframed syncs the conversation to the video so whether it’s an hour, a week or a month later, people can join in the conversation - in context. In this way Reframed gathers text that describes the content of a video at a specific point. This is very useful for the content owners and also allows Reframed to deliver specific moments within a video in search results. So rather than just displaying the videos that include certain content in the search results, Reframed can deliver the exact moments. Live chat style discussion Comments also facilitate further discussions, which are displayed outside of the flow of the video due to their size. This provides the functionality to publicly discuss the moments within the video in much more detail. Users can participate in multiple discussion threads at the same time. And all of the activity around each video is available in “real time”, which means other people’s comments are added to the page without having to refresh it. Comments can be tweeted and a link provided to bring more viewers to the exact point in the video at which the comment was made, known as “deep linking’. Our integration with Twitter goes further, as the entire video also appears in the Twitter timeline and plays from the moment the comment references. This functionality is known as “Twitter Player Cards” and in order to get them you have to apply to Twitter through a very long process. Twitter worked closely with us to speed u p the process and we are in discussion with them about how we can become more deeply integrated, This could include adding replies and retweets around the video and becoming a media partner on their Amplify programme. Platform independent Reframed works with many different video formats, including YouTube, Vimeo, Video.js and self-hosted video. This allows users to comment on and store comments on videos across all these platforms. So whether it’s a TED Talk on YouTube or a documentary on Vimeo, users can keep track of all their comments made on all the videos they have viewed using Reframed. This feature has been described as “Pinterest for moments in video”. Reframed acts as the glue between video, which can be archived and distributed throughout the web and social media platforms. So it’s all abuout what’s current and what’s relevant. Reframed increases engagement, audience reach and monetisation. Channels Channels are a way to group a user’s videos in one place with full moderation tools, which allows the channel owner to promote, hide and edit comments, enabling them to curate interesting videos and influence the conversation. Embeddable player The embeddable player brings all the functionaliy of the Reframed player to any website. The interface can be customised to match the look and feel of any website. Just like the channels, the website owner has full moderation tools to promote, hide and edit comments. Certain accounts can be given “Featured User” priveleges, which allows their comments to take centre stage.

Dukosi

Venture Round in 2018
Dukosi Ltd designs, develops, and manufactures battery management systems for automotive industry. It offers cell sensor products for hybrid, plug-in hybrid, and electric automotive vehicles; mobility vehicles; and smart grids. The company’s products enable monitoring the health of individual battery cells. Dukosi Ltd was founded in 2003 and is based in Edinburgh, United Kingdom.

Canopus

Series A in 2021
Canopus Networks Pty Ltd develops software defined networking and artificial intelligence technologies. It offers internet service providers to isolate streaming video and gaming flows, and protect user experience during periods of network contention and congestion. It serves to fixed operators, gaming, 5g mobile operators, live video streaming, business application, security, and government. The company was founded in 2018 and is based in Sydney, Australia.

Carisma Therapeutics

Private Placement in 2018
CARISMA Therapeutics Inc., a biotechnology company, develops CAR macrophages, an approach to immunotherapy. CARISMA Therapeutics Inc. was formerly known as CARMA Therapeutics Inc. and changed its name to CARISMA Therapeutics Inc. in June 2018. The company was incorporated in 2016 and is headquartered in Philadelphia, Pennsylvania.
Ieso Digital Health Ltd. provides online evidence-based mental health therapy. The company’s online talking therapy service provides an environment for patients dealing with common mental health conditions, such as anxiety, bereavement, child and family, depression, eating disorders, managing anger, managing pain, obsessive compulsive disorder, panic, phobias, post-traumatic stress, relationships, sexual difficulties, sleep, stress management, substance misuse, and terminal illness. It also provides services for people with chronic physical health problems, medically unexplained symptoms, and mild learning disability/cognitive impairment. The company provides one-to-one therapy using an online service that enables patients to meet their accredited therapist in a virtual environment at a time and location that is convenient for them. It serves health providers, including the NHS; private individuals; and businesses. Ieso Digital Health Ltd. was formerly known as PsychologyOnline.co.uk Limited and changed its name to Ieso Digital Health Ltd. in January 2015. The company was founded in 2000 and is based in Swavesey, United Kingdom.

Spirea Ltd.

Pre Seed Round in 2018
Spirea Ltd. operates as a healthcare technology company that has developed a smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines.

Aptatek Biosciences

Seed Round in 2022
Aptatek Biosciences Inc manufactures portable disease management devices for people suffering with Phenylketonuria (PKU). The products can be used to monitor phenylalanine levels. The product provides real time analyses and reports of blood using sensor technology. Aptatek Biosciences Inc is based in Princeton, New Jersey.

Odimax

Seed Round in 2012
Social sales leads: Identified – Nurtured – Delivered. Our proprietary technology identifies sales leads from social conversations, and analyses each individual to inform our teams’ communications with them. Our social engagement experts then gently but effectively nurture leads to the point of purchase for you to convert. You only pay for the qualified sales leads delivered to you for conversion! Odimax Ltd was founded in 2011 as a social media analytics company, and graduated from the ignite100 accelerator programme later that year. Since inception we’ve developed advanced natural language processing (text analytics) and intent-analysis technologies to take advantage of the opportunities presented to businesses by the spread of social media. We do one thing, and we believe we do that best - We combine our innovative technology with the expertise of our social media engagement team to help organisations generate sales from social media.

Papertrail.io

Seed Round in 2013
Ensure inspections are never missed. Save time, money and reduce risk.

Storm Therapeutics

Private Placement in 2016
Storm Therapeutics Limited discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer. Storm Therapeutics Limited was formerly known as Iceni Therapeutics Limited and changed its name to Storm Therapeutics Limited in June 2016. The company was incorporated in 2015 and is based in Cambridge, United Kingdom.
Auspherix Pty Ltd. engage in the discovery and development of a organogold-based antibiotics for serious and difficult to treat or potentially life-threatening infections The company was incorporated in 2013 and is based in Stevenage, United Kingdom.

Givey

Seed Round in 2012
Givey is a social donation platform seeking emphasise the power of giving a little every day. It is completely free to use for both users and charities. Givey make it easy for users to claim Gift Aid on all of their donations, and their partnership with the Paypal Giving Fund makes giving simple and instantaneous. Through 'Givey For Business', businesses can increase employee engagement by choosing to match the money their employees raise and donate to charity. All of this information is stored on a public Givey page, for employees, and the world, to see. Givey currently support over 8,000 charities.

Exyn Technologies

Private Placement in 2019
Exyn Technologies is a spin-off of the GRASP Laboratory at the University of Pennsylvania and is commercializing over a decade of research and development in the area of autonomous flight and aerial robotics. Exyn is creating drone platforms that do not rely on human control or GPS information. Exyn's unique technology is built upon the fusion of multiple redundant sensors, mapping for obstacle avoidance, and autonomous flight planning. Exyn’s robots are highly differentiated and robust, making them ideal and practical for complex commercial environments.
Capsant Neurotechnologies Limited provides pre-clinical assay services to the drug development industry. The company focuses on drug evaluation in the field of clinical neurosciences. It develops assay models that are based on organotypic hippocampal slice cultures and facilitate direct evaluation of potential lead molecules. Capsant was founded in 2002 and is based in Southampton, United Kingdom.

Yippee

Seed Round in 2012
Yippee
Absynth Biologics Limited discovers and develops vaccines and antibodies to prevent and treat bacterial infections. It develops vaccines and therapeutic antibodies against staphylococcus aureus, clostridium difficile, and streptococcus pyogenes. The company develops products based on a platform for identifying novel protein antigen targets that harness the immune system and use a dual-action mechanism, including direct antibacterial activity by antibody-mediated inhibitory effect; and engagement of classic immune effector functions to eliminate the bacteria. Absynth Biologics Limited was founded in 2007 and is based in Alderley Edge, United Kingdom.

Navenio

Seed Round in 2016
Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons or wi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice. The company was founded in 2015 and is headquartered in Oxford, England.
Lumiode is a New York City-based semiconductor technology startup specializing in high-brightness microdisplays for augmented reality and other display applications. Lumiode is venture-backed by IP Group and Applied Ventures.

Gripable

Series A in 2022
Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.
Creavo Medical Technologies Ltd. operates as a medical device company that develops imaging technologies. It offers a battery powered and portable medical device for the detection of heart-related problems in acute medical settings. Creavo Medical Technologies Ltd. was formerly known as Quantum Imaging Limited and changed its name to Creavo Medical Technologies Ltd. in September 2016. The company was incorporated in 2014 and is based in Coventry, United Kingdom.
WaveOptics, Ltd. manufactures augmented reality display technology. Its technology includes binocular display, high field-of-view, full RGB color, and lightweight features. WaveOptics, Ltd. has strategic partnerships with Compal and Wistron, and Plessey. The company was incorporated in 2012 and is headquartered in Abingdon-on-Thames, United Kingdom.
Encos Limited develops and manufactures materials used in the construction industry. It offers masonry units, such as masonry bricks, brick slips, and blocks for testing and trials. Encos Limited was founded in 2007 and is based in Leeds, United Kingdom.

Garrison Technology Limited

Private Placement in 2018
Garrison Technology Limited develops technologies for enterprise cyber security needs. The company was incorporated in 2014 and is based in London, United Kingdom.
AccelerComm Ltd provides Forward Error Correction (FEC) or channel coding solutions. It provides error correction decoder for markets, such as 3G and 4G Mobile handsets and base stations, satellite standards, and communication applications. The company’s products, include Polar, 3GPP Compliant Encoding/Decoding Chain; Turbo Decoder; and LDPC, 3GPP Compliant LDPC Encoding/Decoding Chain. AccelerComm Ltd was incorporated in 2016 and is based in Southampton, United Kingdom.

Aqdot

Private Placement in 2019
Aqdot‘s technology allows for an energy- and raw material-efficient way of manufacturing microcapsules, leading to lower energy consumption and less waste. Potential applications include encapsulating enzymes in laundry detergents, or encapsulating fertilisers in the agrochemical sector. Microencapsulation is a multi-billion-per-annum industry with established applications in household and personal care, food and agrochemical markets.

Oxford Advanced Services

Oxford Advanced Services delivers coatings technology based on carbene chemistry. Its coatings can be used to produce dramatic changes in the surface properties of normally inert materials, such as polyethylene and glass, as well as Teflon and diamond. The technology provides a platform that permits the modification of a range of commodity materials to deliver various functionalities. Its initial applications include colouration, adhesion, and biocidal activity in markets ranging from polymer display screens to water purification. The company is based in the United Kingdom.
NEXEON Limited operates as a battery materials and licensing company that develops silicon anodes for lithium-ion batteries. It offers silicon anode technology solutions for various applications, including consumer electronic, electronic vehicle, sustainable energy, aerospace, medical, and defense industries in the United Kingdom and internationally. The company was founded in 2006 and is based in Abingdon, United Kingdom with an additional office in Yokohama, Japan.
Calcico is a venture backed biotechnology company focused on the development of novel CRAC channel inhibitors. The company aims to develop selective small molecules to treat a range of inflammatory and autoimmune conditions where there is clear evidence linking CRAC to human disease. Calcico is an Oxford based start up which was formed in April 2012 and funded by Advent Life Sciences and Touchstone Innovations. The company has developed proprietary ‘know-how’ comprising novel systems for selective CRAC channel screening and molecule characterisation. This puts us in a unique position to achieve the goal of potent and selective CRAC channel inhibition, which has so far eluded pharmaceutical companies.
Top Technology Ventures is a UK-based venture capital company which specialises in providing equity funding for early stage technology based growth companies.
Zilico Limited develops diagnostic devices that remove subjectivity, increase accuracy, and deliver results in real-time. It deals with electrical impedance spectroscopy technology for a range of neoplastic conditions; and provides ZedScan, a diagnostic system that is used alongside colposcopy to provide an objective assessment of the cervical epithelial tissue in real time. The company was formerly known as Aperio Diagnostics Limited and changed its name to Zilico Limited in July 2008. Zilico Limited was founded in 2006 and is based in Manchester, United Kingdom with an additional office in Sheffield, United Kingdom.
CatalySystems Limited provides photocatalytic water treatment solutions to decontaminate organic compounds from water and wastewater. The company offers GYRECAT products and solutions that are based on photocatalysis, a new breed of hybrid advanced oxidation process (AOP) that releases an oxidizing agent to oxidize a range of organic compounds found in water and wastewater. Its products include GYRECAT, which is a containerized plant consisting of a number of GYRECAT modules to meet the application requirement; and GYRECAT Nexus, which is a modular small-scale unit for deployment in agri-rural locations to treat brackish waters from boreholes for irrigation and cattle drinking stations. The company’s GYRECAT products are used for reducing TOC and COD, as well as treating pathogens, bacteria, and viruses. It provides project FEED, detailed engineering, manufacturing, assembly, installation, commissioning, and operation and maintenance services to integrate the GYRECAT systems into the process train. The company’s products are used for various applications in agricultural, industrial, onshore oil and gas, commercial and community, and greywater recycling sectors in the United Kingdom and internationally. CatalySystems Limited was incorporated in 2009 and is based in Middlesbrough, United Kingdom.
iQur is at the forefront of vaccine research and development, using tandem core technology to create novel vaccines, currently being developed for influenza, malaria, human cytomegalovirus, dengue fever and hepatitis C. At iQur we are designing vaccines to provide protection against major global health challenges. We are targeting several different viruses using our patented proprietary technology and hope to bring benefit to people around the world by protecting them against a range of major pathogens.
Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally. We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when you need it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times. Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life.
Bramble Energy Ltd. designs, develops, and manufactures printed circuit board (PCB) fuel cell – the PCBFC, which helps the PCB industry in the manufacturing of proton exchange membrane fuel cells (PEMFCs). The company's products include Bramble Energy 20 W PCBFC stack, Bramble Energy 500W PCBFC stack, Bramble Energy 5kW PCBFC stack, and Bramble Energy custom design PCBFC. It serves to stationary, portable, and automotive and mobility sectors. The company was incorporated in 2015 and is based in London, United Kingdom.
Oxford Nanopore Technologies Limited develops and commercializes nanopore-based electronic systems for analysis of single molecules. The company offers MinION, a portable device for molecular analysis based on nanopore technology and is adaptable for the analysis of DNA, RNA, proteins, and small molecules; MinIT, an analysis and device control accessory for nanopore DNA sequencing; PromethION, a tablet-sized benchtop instrument that provides real-time data streaming; GridION system for molecular sensing applications; 109 cDNA Kits for its real-time and scalable sequencing technology that provides high throughput whilst generating complete sequences of full-length cDNA strands; and Flongle, a paradigm of smaller on-demand DNA or RNA sequencing tests with the potential to transform a range of applications where insights are required at low cost. Its devices are used in scientific research, personalized medicine, crop science, and security and defense applications. The company sells its products online. Oxford Nanopore Technologies Limited was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies Limited in May 2008. The company was incorporated in 2005 and is based in Oxford, United Kingdom with additional offices in the United Kingdom, the United States, China, Japan, Germany, France, India, and Singapore.

Moltin

Seed Round in 2013
Moltin Limited develops and delivers a cloud based eCommerce platform for developers. Its eCommerce platform provides APIs for building an online store and a mobile application, and creating virtual reality retail experience. The company’s APIs help to manage inventory, categorization, imagery, brands, and collections; secure cross-platform shopping carts and streamline checkout flow; integrate payments process; extend and create new data models; and more. The company’s platform also offers Forge, an administration dashboard to manage stores. It serves developers and store owners. Moltin Limited was incorporated in 2013 and is based in Newcastle upon Tyne, United Kingdom. As of January 13, 2020, Moltin Limited operates as a subsidiary of Elastic Path Software Inc.
First Light Fusion Limited discovers advanced implosion processes for electricity generation. First Light Fusion Limited was formerly known as Oxyntix Ltd. and changed its name to First Light Fusion Limited in June 2014. The company was founded in 2011 and is based in Begbroke, United Kingdom.

Abliva AB

Post in 2022
Abliva develops cyclosporine-based mitochondrial-protecting pharmaceuticals for the treatment of traumatic brain injuries (TBIs), reperfusion injury in myocardial infarction, stroke, and other acute injuries. Their advanced research program focuses on developing additional variants of cyclophilin-D-inhibiting cyclosporines and studying new ways of transporting these drugs across the blood-brain barrier to the central nervous system. Their NeuroSTAT pharmaceutical is currently entering into a Phase II/III adaptive clinical study for TBI, while their CicloMulsion® pharmaceutical for reperfusion injury is in a 1,000-patient, Phase III, investigator-initiated clinical study.

Azellon Limited

Venture Round in 2011
Azellon Limited develops and commercializes a platform technology using mesenchymal stem cells infused into a biological scaffold for tissue repair. The company offers Cell Bandage, a tissue repair technology that is used in the repair of tears of the avascular (white) zone knee meniscus. Its technology combines one’s own bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. Azellon Limited was incorporated in 2007 and is based in London, United Kingdom.

Diffblue

Seed Round in 2022
Diffblue is changing the way software is developed using Artificial Intelligence (AI). Diffblue Cover, the company’s first product, automatically generates tests for Java code to enable development teams to deliver higher quality software, faster. Diffblue’s technology is developed by its team of leading experts in AI, software verification and synthesis, and customers include Goldman Sachs and Amazon Web Services. Diffblue is backed by Oxford University, Oxford Sciences Innovation and Goldman Sachs and is headquartered in Oxford, UK.

Microbiotica

Series B in 2022
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and in vivo models.
Pharminox is engaged in the discovery, research and development of novel small molecule drugs to treat common forms of cancer, with a specific research focus on molecularly targeted DNA damage and inhibition of DNA damage repair mechanisms.
Silicon Microgravity Limited develops sensor devices for the oil and gas sector. Its sensing technology enables the recording of gravity data at high sensitivities and seismic data at ultra-low frequencies. The company offers microelectromechanical system sensors to transform measuring densities deep in the reservoir from the borehole. Its technology is also used in the navigation, guidance, and stabilization or directing of intelligent systems for commercial, industrial, and military applications. The company was founded in 2014 and is based in Cambridge, United Kingdom.

Vytal

Series A in 2022
VYTAL Global GmbH develops a digital reusable system for take-away, delivery, and convenience food. It offers VYTAL, an application that allows to choose reusable bowl instead of disposable in the store and show the QR code in the app / on the membership card to borrow bowls and return it to any partner or in its return boxes. It serves consumers, restaurants, canteens, caterers, companies, grocers, and cities and municipalities. The company was founded in 2019 and is based in Cologne, Germany.

Ditto

Private Placement in 2018
A company at the top of its game in harnessing intelligent systems and emerging technologies. Working methodically but unobtrusively they set the gold standard in workplace automation. You can trust our proprietary and proven methodology to encapsulate your human know-how and the complex processes that characterise human decision-making.
Uniformity Labs, Inc. manufactures additives, such as feedstock powders for use in three dimensional printing. The company was incorporated in 2014 and is based in Fremont, California.
Magnomatics is a high technology spin-out company from the largest electrical machines research group in the UK. Magnomatics was established in 2006 as a spin-out from the University of Sheffield to commercialise ground-breaking research on magnetic transmission systems, high-torque electrical machines and electromechanical actuators and dampers being undertaken by Dr Kais Atallah and Professor David Howe in the Electrical Machines and Drives research group at the University.

Genomics

Private Placement in 2018
Genomics PLC develops algorithms and software solutions that focus on cancer, microbes, and rare diseases. Its solutions allow governments and healthcare providers to transform healthcare provisions for their citizens and members; pharmaceutical and biotechnology clients to de-risk the drug development process; clinicians and doctors to improve diagnoses and treatment options; and research laboratories and genome analysts to process results accurately. The company was incorporated in 2014 and is based in Oxford, United Kingdom.
Ultraleap is the world leader in mid-air haptics and 3D hand tracking. The company's breakthrough haptic technology (previously Ultrahaptics) uses ultrasound to create rich, three-dimensional shapes and textures that can be felt, but not seen.

Kynos Therapeutics

Seed Round in 2022
Kynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.
ReOx Ltd. engages in research and development of drugs for treatments of disease by controlling the activity of hypoxia inducible factor. The company was incorporated in 2003 and is based in the United Kingdom.

Document IP Limited

Document IP Limited is based in Watford, United Kingdom.
Parkwalk Advisors Ltd, Advisory Arm operates as a subsidiary of Parkwalk Advisors Ltd.
Pulmocide Ltd, a company focused on the discovery and development of a new generation of inhaled medicines for the treatment of serious viral and fungal infections of the respiratory tract.
Featurespace Limited provides adaptive behavioral analytics solutions for fraud prevention and customer management applications. The company offers ARIC engine, a real-time, machine learning fraud management software platform that understands the behavior of each individual customer. Its solutions include ARIC fraud manager, a software platform for fraud detection, reporting, and case management; ARIC accept that understands the optimal payment route for each individual customer; and ARIC responsible gambling, a solution to demonstrate responsible gambling compliance while gaining customer insight. The company serves banks, insurance companies, and gaming organizations. Featurespace Limited was founded in 2005 and is based in Cambridge, United Kingdom with additional offices in Georgia and London.
Applied Graphene Materials plc produces and sells graphene products primarily in the United Kingdom. It offers graphene nanoplatelets; and graphene powder in a range of polymer matrices, including thermoset and thermoplastic, as well as adhesives, elastomers, oils, and aqueous and non-aqueous solutions. The company provides its products for use in advanced composites and polymers; thermal management solutions; coatings; barriers and impermeable films; functional fluids, such as oils and lubricants; display materials and packaging; capacitors and batteries; and inks and 3D printed materials. Applied Graphene Materials plc was founded in 2010 and is based in Redcar, the United Kingdom.